CTLT – catalent, inc. (US:NASDAQ)
Stock Stats
News
11/22
03:37 am
ctlt
Neutral
Catalent, Inc. (NYSE: CTLT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/21
06:14 am
ctlt
Low
FDA (Food and Drug Administration) Drug Approval Process Training Course: Comprehensive Programme Covering Procedures for Submission of INDs, NDAs, ANDAs and 505(b)(2) (LIVE ONLINE EVENT/ON-DEMAND) [Yahoo! Finance]
11/20
07:07 am
ctlt
Low
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery [Yahoo! Finance]
11/18
08:00 am
ctlt
Low
Matica Biotechnology Appoints Life Sciences Leader Min Park, MBA to Chief Commercial Officer [Yahoo! Finance]
11/18
07:12 am
ctlt
Low
Pharmaceutical Outsourcing Launches New Clinical Trials Documentary: Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs [Yahoo! Finance]
8/29/2024
07:30 am
CTLT
1.6%
MISS
2/9/2024
07:59 am
CTLT
0.5%
MISS
9/24
08:09 am
Reiterates
Outperform
Neutral
Robert W. Baird
Low
0.8%
9/24
06:40 am
Downgrades
Outperform
Neutral
Baird
Low
0.7%
9/24
06:40 am
Downgrades
Outperform
Neutral
Baird
Low
0.7%
9/3
11:09 am
Reiterates
Market Perform
William Blair
Low
0.0%
9/3
11:09 am
Reiterates
Market Perform
William Blair
Low
0.0%
11/14
04:35 pm
ctlt
Low
Form SC 13G/A Catalent, Inc. Filed by: NOMURA HOLDINGS INC
11/14
02:46 pm
ctlt
Low
Form 4 Catalent, Inc. For: Nov 11 Filed by: Ryan Michelle R
11/14
09:50 am
ctlt
Low
Form SC 13G/A Catalent, Inc. Filed by: JANUS HENDERSON GROUP PLC
11/13
12:53 pm
ctlt
Low
Form SC 13G/A Catalent, Inc. Filed by: Capital World Investors
11/12
11:21 am
ctlt
Low
Form 144 Catalent, Inc. Filed by: Ryan Michelle R
Show more
Top News Gainers
3/17 Catalent Partners with Biohaven on New Fast-Dissolve Migraine Treatment 10.2%
4/29 Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate 9.5%
3/9 Catalent, Inc. to Present at the Barclays Global Healthcare Conference 7.8%
6/21 Catalent Inc (NYSE: CTLT) was upgraded by analysts at Jefferies Financial Group Inc from a "hold" rating to a "buy" rating. 5.9%
12/17 Catalent to Host Workshop to Discuss Accelerating Early Drug Development through Consultant Collaboration 4.9%
12/18 Catalent Inc (NYSE: CTLT) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.2%
3/3 Form 8-K Catalent, Inc. For: Mar 02 3.9%
4/13 Catalent Publishes Fiscal 2019 Corporate Responsibility Report 3.6%
3/2 Catalent Inc (NYSE: CTLT) is now covered by analysts at Deutsche Bank AG. They set a "hold" rating and a $59.00 price target on the stock. 3.5%
1/13 Age-Appropriate Formulation Development for Pediatric Trials: Challenges and Considerations, Upcoming Webinar Hosted by Xtalks 3.1%
Top News Decliners
3/17 Vectura Group PLC (VEGPF) CEO Will Downie on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -13.9%
8/27 Catalent Earnings Unexpectedly Rise [Investor's Business Daily] -5.4%
2/27 Catalent Announces Supplying Blueprint Medicines' Precision Therapy AYVAKIT™ (avapritinib) -4.8%
4/30 Form 8-K Catalent, Inc. For: Apr 30 -4.2%
5/7 Q3/2019 3/31/2019 EPS 0.220 ZacksConsensus 0.420 ActVsEst (0.200) - Miss -3.9%
2/24 Catalent's Senior Vice President & Chief Financial Officer, Wetteny Joseph, Inducted as a Member of the Executive Leadership Council -3.6%
2/3 Catalent, Inc. Announces Public Offering of Common Stock -3.5%
2/20 Catalent to Host Workshop Demonstrating Advantages of Integrated Biologics Development Solutions in London, U.K. -3.1%
3/27 Catalent Inc (NYSE: CTLT) had its price target lowered by analysts at Morgan Stanley from $67.00 to $57.00. They now have an "overweight" rating on the stock. -3.0%
4/20 Catalent Inc (NYSE: CTLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating on the stock. -2.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3